NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA
NCT01553851 2016-12-26GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell CancerWashington University School of MedicinePhase 2 Completed20 enrolled 13 charts